Sontheimer R D, McCauliffe D P
Dermatol Clin. 1990 Oct;8(4):751-8.
Patients with several clinically distinctive types of cutaneous LE (e.g., SCLE, neonatal LE) frequently are found to have autoantibodies to the Ro RNP particle present in their circulation. Some studies suggest that these antibodies might be capable of directly triggering the type of histopathologic changes seen in SCLE and neonatal LE through immunologic effector mechanisms such as ADCC. Other investigative results, however, are not compatible with this hypothesis. A better understanding of the molecular configuration of the Ro small cellular RNP particle, the factors that regulate the expression of this complex autoantigen system in epidermal keratinocytes, and the overall pathogenetic potential of the Ro autoimmune response should provide some insight into this seeming paradox.
患有几种临床特征明显的皮肤红斑狼疮(如亚急性皮肤型红斑狼疮、新生儿红斑狼疮)的患者,其循环中常可检测到针对Ro核糖核蛋白颗粒的自身抗体。一些研究表明,这些抗体可能能够通过免疫效应机制(如抗体依赖的细胞介导的细胞毒作用)直接引发亚急性皮肤型红斑狼疮和新生儿红斑狼疮中所见的组织病理学变化类型。然而,其他研究结果并不支持这一假说。更好地了解Ro小细胞核糖核蛋白颗粒的分子结构、调节该复杂自身抗原系统在表皮角质形成细胞中表达的因素,以及Ro自身免疫反应的整体致病潜力,应该能为这一明显的矛盾提供一些见解。